Entrada Therapeutics Inc (TRDA) Insider Trading
- $891,442.45
- $2,903,841.93
- April 8, 2024
- Dipal Doshi
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Sept. 23, 2022 | Insider | 939 | $15.09 | Sell | $14,169.51 | |
| Sept. 23, 2022 | COO | 1,018 | $15.07 | Sell | $15,341.26 | |
| Sept. 21, 2022 | COO | 3,275 | $15.13 | Sell | $49,550.75 | |
| Sept. 21, 2022 | Insider | 3,341 | $15.08 | Sell | $50,382.28 | |
| Sept. 21, 2022 | CEO | 3,402 | $15.12 | Sell | $51,438.24 | |
| Sept. 15, 2022 | COO | 100 | $15.01 | Sell | $1,501.00 | |
| Sept. 15, 2022 | CEO | 200 | $15.04 | Sell | $3,008.00 | |
| Sept. 15, 2022 | Insider | 106 | $15.01 | Sell | $1,591.06 | |
| Sept. 9, 2022 | Insider | 800 | $15.07 | Sell | $12,056.00 | |
| Sept. 8, 2022 | CEO | 1,100 | $15.16 | Sell | $16,676.00 | |
| Sept. 8, 2022 | COO | 912 | $15.15 | Sell | $13,816.80 | |
| Aug. 31, 2022 | CEO | 171 | $12.00 | Sell | $2,052.00 | |
| Aug. 29, 2022 | CEO | 1,639 | $12.88 | Sell | $21,110.32 | |
| Aug. 25, 2022 | CFO | 1,551 | $14.18 | Sell | $21,993.18 | |
| Aug. 23, 2022 | CFO | 2,909 | $13.09 | Sell | $38,078.81 | |
| Aug. 18, 2022 | CFO | 200 | $13.00 | Sell | $2,600.00 | |
| Aug. 16, 2022 | CFO | 200 | $13.00 | Sell | $2,600.00 | |
| July 27, 2022 | CEO | 2,000 | $12.00 | Sell | $24,000.00 | |
| June 27, 2022 | CEO | 4,000 | $12.00 | Sell | $48,000.00 | |
| June 27, 2022 | COO | 7,714 | $13.00 | Sell | $100,282.00 | |
| June 6, 2022 | Major Shareholder | 38,304 | $6.41 | Buy | $245,528.64 | |
| June 2, 2022 | Major Shareholder | 2,643 | $5.82 | Buy | $15,382.26 | |
| May 23, 2022 | Major Shareholder | 7,837 | $5.99 | Buy | $46,943.63 | |
| May 20, 2022 | Major Shareholder | 16,849 | $5.84 | Buy | $98,398.16 | |
| May 18, 2022 | Major Shareholder | 34,433 | $6.00 | Buy | $206,598.00 | |
| May 16, 2022 | Major Shareholder | 19,000 | $5.83 | Buy | $110,770.00 | |
| Jan. 12, 2022 | Director | 5,000 | $9.71 | Buy | $48,550.00 |
Insiders are both buying and selling Entrada Therapeutics Inc stock.
The insider traders at Entrada Therapeutics Inc are: Dipal Doshi, Nathan J Dowden, Kory James Wentworth, Nerissa Kreher, Bros. Advisors Lp Baker, Peter S Kim, Natarajan Sethuraman, and John F Crowley
The most active insider trader at Entrada Therapeutics Inc is Dipal Doshi with 28 trades.
Dipal Doshi has sold the most Entrada Therapeutics Inc stock with a total value of $835,721.49.
Bros. Advisors Lp Baker has bought the most Entrada Therapeutics Inc stock with a total value of $969,149.33.
The most recent insider trade for Entrada Therapeutics Inc was on April 8, 2024.
The single biggest insider buy for Entrada Therapeutics Inc was from Bros. Advisors Lp Baker with a total value of $245,528.64 on June 6, 2022.
The single biggest insider sell for Entrada Therapeutics Inc was from Kory James Wentworth with a total value of $262,675.00 on June 21, 2023.